Replies to post #349071 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

But now you are changing the venue of the storyline.

SAB, consultants, etc as well as a full, deep dive, into the details relevant to such disclosure. You don’t want to make a disclosure only to reverse/modify it later after you have done a deep dive into the details.

Now you introduce a narrative into the story where after looking into the data in detail perhaps and maybe there may be some sort of FDA approved. I have never said that.

I have repeatedly said that if after it has become absolutely undeniable clear, with the help of the independent statisticians, that in no shape or form NWBO could get approval for its most important, only product DCVAXL then that sole product is no longer viable. If that vital product is no longer available to be offered for sale then that thus changes its cash flow outlook dramatically. If NWBO's income stream worsens to that degree then that is a material event that must be disclosed within 4 business days.

SEC rules are not something we can not disagree with they exist and must be obeyed. NWBO has, what I understood from those that spoke with LG, recognized that.